Artha Sootra - Company Dashboard

Governance Classic Home

Onesource Specialty Pharma LtdPharmaceuticalsINE013P01021Consolidated₹1580.75+13.70 (+0.87%)

Valuation

Market Cap₹18.16K Cr

TTM PE780.10x

Forward PE121.57x

PEG-5.28

Book Value₹516.45

P/B3.07x

TTM EPS₹2.03

Fwd EPS₹13.03

TTM Revenue₹2.13K Cr

TTM PAT₹23.38 Cr

TTM EBITDA₹519.23 Cr

TTM EBIT₹159.21 Cr

Last Qtr PAT₹82.48 Cr

Last Qtr EBITDA₹286.64 Cr

Last Qtr EBIT₹139.84 Cr

Profitability

ROE0.39%

ROCE3.26%

TTM NPM1.10%

TTM EBITDA %24.34%

Curr OPM8.50%

Last OPM5.52%

Curr NPM—

Last NPM—

Curr EPS₹7.19

Last EPS₹2.18

Balance sheet

Equity₹11.47 Cr

Reserve₹5.91K Cr

Total Debt₹1,754.86 Cr

D/E0.30x

Interest %79.26%

Curr Interest₹65.37 Cr

Price / range

Close₹1583.60

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D+0.95%

1W+0.46%

1M+4.70%

3M+3.05%

6M-9.99%

1Y-13.27%

2Y—

3Y—

5Y—

Diwali-11.48%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1773.40	₹4.25L Cr	38.81	12.31%
DIVISLAB	10037.50	₹2.66L Cr	91.08	17.45%
TORNTPHARM	4738.50	₹1.60L Cr	77.77	11.42%
LAURUSLABS	2323.80	₹1.25L Cr	93.63	21.98%
ZYDUSLIFE	1188.10	₹1.20L Cr	28.53	15.79%
DRREDDY	1374.00	₹1.15L Cr	40.89	7.11%
CIPLA	1402.00	₹1.13L Cr	39.09	8.06%
MANKIND	2537.90	₹1.05L Cr	46.71	12.87%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	960.97+156.1%	446.47	418.96	290.22	375.19	1,405.38
Other Income	4.71	3.79	2.09	4.62	3.04	15.01
Total Income	965.68+155.3%	450.26	421.06	294.84	378.22	1,420.39
Interest	64.70	30.52	22.25	37.99	33.31	120.58
Expenditure	-828.26-142.8%	-399.03	-401.25	-349.94	-341.12	-1,393.76
PBDT	0	0	0	0	0	0
EBITDA	272.63+168.4%	114.14	74.70	12.84	101.59	269
Depreciation	-75.22	-36.18	-34.74	-34.57	-34.21	-136.80
EBIT	197.41+193.0%	77.96	39.96	-21.73	67.38	132.20
PBT	137.42+270.4%	51.23	21.48	-62.19	37.10	21.21
Tax	0	0	0	0	0	0
Equity	11.47	11.46	11.46	11.46	0	11.46
OPM	14.23	11.38	5.10	-21.09	9.89	1.49
Net Profit	137.42+270.4%	51.23	21.48	-62.19	37.10	21.21
NPM	14.23	11.38	5.10	-21.09	9.89	1.49
EPS	11.98+269.8%	4.47	1.87	-5.43	3.24	1.85

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25
Revenue	1,405.38+8.1%	1,299.59
Other Income	15.01	17.68
Total Income	1,420.39+7.8%	1,317.27
Expenditure	-1,393.76-13.6%	-1,226.48
Interest	-120.58	-161.65
PBDT	0	0
EBITDA	269-27.2%	369.27
Depreciation	-136.80	-134.51
EBIT	132.20-43.7%	234.76
PBT	21.21+198.8%	-21.46
Tax	0	41.46
Equity	11.46	11.44
OPM (%)	1.49	-1.63
Net Profit	21.21+9.8%	19.31
NPM (%)	1.49	1.47
EPS (Rs)	1.85+2.2%	1.81
CEPS	1.85	1.81

Metric	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	965.27+156.9%	449.02	428.22	290.34	375.76	1,421.59
Other Income	4.76	3.80	2.09	4.63	3.04	15.02
Total Income	970.02+156.1%	452.83	430.31	294.97	378.80	1,436.61
Interest	65.37	30.81	22.51	38.23	33.96	122.19
Expenditure	-890.80-138.8%	-428.23	-430.64	-380.89	-373.06	-1,518.65
PBDT	0	0	0	0	0	0
EBITDA	286.64+169.2%	123.35	91.92	17.32	106.49	304.22
Depreciation	-146.80	-71.75	-71.83	-69.64	-69.83	-279.09
EBIT	139.84+281.5%	51.60	20.09	-52.32	36.66	25.13
PBT	73.16+1174.6%	20.29	-0.29	0	5.74	-91.96
Tax	9.32	4.70	4.89	4.31	4.74	18.16
Equity	11.47	11.46	11.46	0	0	11.46
OPM	7.54	4.48	-0.07	0.00	1.52	-6.40
Net Profit	82.48+686.3%	25	4.60	-88.70	10.49	-73.80
NPM	8.50	5.52	1.07	-30.07	2.77	-5.14
EPS	7.19+681.5%	2.18	0	-7.74	0.92	0

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25
Revenue	1,421.59-1.6%	1,444.85
Other Income	15.02	17.47
Total Income	1,436.61-1.8%	1,462.33
Expenditure	-1,518.65-7.1%	-1,418.55
Interest	-122.19	-166.32
PBDT	0	0
EBITDA	304.22-34.8%	466.50
Depreciation	-279.09	-273.88
EBIT	25.13-87.0%	192.62
PBT	-91.96-37.1%	-67.07
Tax	18.16	49.79
Equity	11.46	11.44
OPM (%)	-6.40	-4.59
Net Profit	-73.80-310.7%	-17.97
NPM (%)	-5.14	-1.23
EPS (Rs)	0	0
CEPS	0	0

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

No dividend history.

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split